Sinomenine prevents monocrotaline-induced pulmonary arterial hypertension by inhibiting osteopontin-mediated PASMC phenotypic switching.
- DOI
- 10.1016/j.ejphar.2026.179545
- Published
- 2026 Nov 9
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179545,
title = {Sinomenine prevents monocrotaline-induced pulmonary arterial hypertension by inhibiting osteopontin-mediated PASMC phenotypic switching.},
author = {Zeng Z and Chen Z and Liu J and Xu W and Qin Y and Lin X and Wu W and Zhou H and Huang X},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179545},
url = {https://doi.org/10.1016/j.ejphar.2026.179545}
}RIS
TY - JOUR TI - Sinomenine prevents monocrotaline-induced pulmonary arterial hypertension by inhibiting osteopontin-mediated PASMC phenotypic switching. AU - Zeng Z AU - Chen Z AU - Liu J AU - Xu W AU - Qin Y AU - Lin X AU - Wu W AU - Zhou H AU - Huang X PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179545 UR - https://doi.org/10.1016/j.ejphar.2026.179545 ER -
APA
Z, Z., Z, C., J, L., W, X., Y, Q., X, L., W, W., H, Z., & X, H. (2026). Sinomenine prevents monocrotaline-induced pulmonary arterial hypertension by inhibiting osteopontin-mediated PASMC phenotypic switching.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179545
Source records
- pubmed · retrieved 2026-11-10T10:37:13.120Z